CHG-2021-0196

Formulation Change for Retinavab. Analytical Method Change for Retinavab — minor update. Impacts 4 markets and 2 variations.

Change Number
CHG-2021-0196
Type
Formulation Change
Product
Retinavab
Status
Draft
Owner
Marcus Webb
Initiated
2022-12-17
Description

Analytical Method Change for Retinavab — minor update

Impacted Markets (4)
JP — JapanTW — TaiwanAR — ArgentinaAT — Austria
Impacted Modules
3.2.P.3
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved